Suppression of apoptosis by survival factors is important for the maintenance of normal tissue homoeostasis and the response to infection or injury. Survival factors such as insulin-like growth factor-I (IGF
Introduction
Our understanding of the role of peptide hormones and cytokines as necessary survival factors for most cells has come from our understanding of the process of cell death (apoptosis). Genetic and biochemical evidence supports the idea that the apoptosis programme is a default pathway during the critical points of a cell's life, such as de-velopment, cell division, in response to viral infection or oncogene activation, and in response to toxic stimuli. All of the effectors and regulator proteins necessary for apoptosis are present in cells at all times, and the process is only kept in check by anti-apoptotic stimuli from sources such as survival factors and anti-death genes.
T h e necessity of maintaining cell survival by suppression of apoptosis has been conserved during evolution from the nematode Caenorhabditis elegans [l] . T h e proteins that regulate apoptosis in C . elegans are analogous to the Bcl-2 family [2] , the caspase family members [3] and Apaf-1 [4] . In this system, 13 1 cells out of a total of 1090 somatic cells are programmed to die in order for a normal worm to develop. T h e functioning of the ced-9 gene (bcl-2 homologue) is essential for C . elegans to develop, and it is required to suppress apoptosis in cells that are needed to survive for development [S] . The activity of ced-9 is blocked by the egl-1 gene product [ 6 ] , which is homologous to the mammalian BH3 (Bcl-2 homology 3)-domain-containing members of the Bcl-2 family, which contains Bak and others [7, 8] . Ced-9 in turn blocks the activity of ced-4 or its mammalian homologue Apaf-1, which is essential for activation of ced-3, a mammalian caspase homologue [9] .
T h e apoptotic programme outlined above is kept in check by survival signals that come either from cell surface contacts or from soluble survival factors such as insulin-like growth factor-I (IGF-I). A precise balance between survival signals, death signals and the regulation of the core cell death machinery is essential for the development and maintenance of healthy cells (Figure 1) . Regulating an intrinsic death programme by external survival signals also provides an innate defence against viral infection and against the survival of damaged cells that could give rise to s7 tumours. However, as discussed below, viral infections and tumours do arise and this can be attributed in many cases to the up-regulation of anti-apoptotic (or survival) mechanisms in response to viral signalling or in response to oncogene activation.
IGF-I as a survival factor
IGF-I and IGF-I1 are single-chain peptides of approx. 70 and 67 amino acids respectively, which were initially characterized as having mitogenic actions as well as insulin-like activities in adipose and muscle tissue, and have overall identity with insulin of approx. 40-50 % (reviewed in [10,11]).
The IGFs are ubiquitously expressed and are produced in large quantities by the liver. Both IGF-I and IGF-I1 are found circulating in serum at high concentrations (100 nM) in association with high-affinity I G F binding proteins, which sequester them away from insulin receptors, facilitate their transport and regulate their biological functions at a cellular level. IGF-I has been recognized for a considerable period of time as an important mitogen for many cell types, but only more recently has its role in the suppression of apoptosis been appreciated. IGF-I protects fibroblasts that have been induced to die by activation of the c-myc oncogenes in media containing low serum [12] or overexpression of the pro-apoptotic Bcl-2 family member Bak [7] . It protects tumour cells and fibroblasts from chemotherapeutic drugs [13], caspase activation [14] or CD95 ligation [15] . 
The IGF-I receptor (IGF-IR) and apoptosis
All of the actions of IGF-I as a survival factor are mediated through the IGF-IR, which is a transmembrane tyrosine kinase receptor that becomes activated by binding of any of three ligands : IGF-I, IGF-11, or insulin at supra-physiological concentrations. The IGF-IR has been shown to mediate mitogenic, transformation and anti-apoptotic activities (reviewed in [10,1 l]), and has been shown to be absolutely essential for normal cell growth and development. Mice that have a targeted disruption of the receptor gene that leads to a null phenotype are 40% of normal size and die early in embryogenesis [18] . The IGF-IR contributes to survival in cells of different origin, including cells derived from the nervous system and from the mesenchyme [13, 17] . Ectopic expression of the IGF-IR enhances the degree of IGF-I-mediated protection in FL5.12 cells and 32D cells [19] .
Suppression of apoptosis by the IGF-IR is a distinct function from the receptor's mediation of mitogenic signals, since it occurs in the presence of cycloheximide, it does not require de novo protein synthesis [ll] , and it is separable from mitogenesis by mutational analysis of the receptor [19, 20] .
There is considerable evidence from mouse models and in vitto systems to support a role for IGF-IR-mediated anti-apoptotic activity in carcinogenesis, where it could suppress apoptosis that is induced by dominant oncogenes such as myc [l 13. In a transgenic carcinogenesis model involving simian virus 40 T antigen targeted to the /?-islet cells, activation of the IGF-IR by IGF-I1 is a critical determinant of carcinogenic progression [21] . Elevated levels of IGF-IR have been detected in human tumours of lung, breast and colon [22-241, and this is often associated with increased levels of circulating IGF-I and/or IGF-11. Antisense inhibition of IGF-IR expression suppresses tumorigenicity of tumour cells introduced into mice, and IGF-IR-blocking antibodies also inhibit tumour growth. All of these studies indicate that the IGF-IR could be a specific target at which to inhibit the survival of tumour cells and make them more susceptible to eradication or drug treatment.
Survival signals from the IGF-IR
The survival signalling pathways from the IGF-IR are at least partially known (reviewed in [ll] ). Upon activation the IGF-IR becomes autophos- [29] , resulting in the sequestration of Bad away from the death suppressor Bcl-xL [30] . Bcl-xL is then thought to be free to remain in a complex with the caspase activator Apaf-1, thus preventing caspase activation and apoptosis [3 11 (Figure 2 ).
Regulation of IGF-lR survival signals
Now that at least one signalling pathway leading from the IGF-IR directly to the core cell death machinery is known, it is of great interest to understand what regulates this pathway. Kinaseregulated signalling pathways are regulated by phosphatases, two of which are known to function in the IGF-IR survival pathway (Figure 3) . One of these is PTEN, which dephosphorylates PtdIns-(3,4,5)P, and thus reverses P13-K-mediated activation of A K T [32] . T h e other phosphatase is calcineurin, which has been shown to dephosphorylate Bad and thus reverse the affects of A K T phosphorylation [33] . Interestingly, P T E N is the product of a tumour suppressor gene, because its gene locus on chromosome 10 (LOH 10q23) exhibits allelic loss and mutation in advanced cancers [34] . P T E N knockout mice are resistant to apoptosis and have increased A K T activity [32] . T h e P T E N phenotype illustrates the importance of the IGF-IR survival signalling pathway in the generation and progression of tumour cells.
Phosphatases that directly regulate the IGF-IR or its phosphorylation of immediate substrates are not known. A phosphatase that specifically regulates the IGF-IR would be a valuable target for manipulating the survival of many cell types, in particular neurons and tumour cells. T o try and identify a role for these subdomains, expression constructs encoding the entire C-terminus and the C-terminus with mutations at these subdomains were generated. Expression of the C-terminal protein in MCF-7 tumour cells or fibroblasts resulted in induction of apoptosis, and this was reversed in the mutants [36, 37] . Therefore the tyrosines at positions 1250/1251 and histidine-1293/lysine-1294 are required for the pro-apoptotic activity of the Cterminus when it is expressed as an isolated domain. Analysis of fragments that contained either one of these subdomains by transfection studies and in vitro kinase assays confirmed the importance of tyrosine-1 250 and -1 25 1. These studies also suggest that the C-terminus of the IGF-IR interacts with or regulates proteins that can suppress anti-apoptotic signalling from the receptor. It is not yet known what these regions of the receptor interact with or how they might regulate the receptor, but current efforts are focused on the signalling pathways that may be affected by the C-terminal proteins.
In conclusion, anti-apoptotic signals from the IGF-IR are likely to be critical for the maintenance of many types of cells, and are particularly important in the survival of tumours. Identification of the regulators that interact with the C-terminus of the receptor to control its antiapoptotic activity could provide a way in which to manipulate the survival of cells.
